Publication Author: Sullivan_Sean

• Evolution of the AMCP Format for Formulary Submissions.

  Watkins JB, Sullivan SD, Sampsel E, Fullerton DSP, Graff JS, Fry RN, Lee J, Tam IM, Avey SG. Evolution of the AMCP Format for Formulary Submissions. J Manag Care Spec Pharm. 2020 Jun;26(6):696-700. doi: 10.18553/jmcp.2020.26.6.696.

  rakerr2

  June 1, 2020

• An Effective Behavioral Nudge in the Operating Room.

  Khandelwal N, Sullivan SD. An Effective Behavioral Nudge in the Operating Room. Anesthesiology. 2020 May;132(5):942-943. doi: 10.1097/ALN.0000000000003225.

  rakerr2

  May 1, 2020

• Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.

  Freemantle N, Mauricio D, Giaccari A, Bailey T, Roussel R, Franco D, Berthou B, Pilorget V, Westerbacka J, Bosnyak Z, Bonnemaire M, Cali AMG, Nguyên-Pascal ML, Penfornis A, Perez-Maraver M, Seufert J, Sullivan SD, Wilding J, Wysham C, Davies M. Real-world

  rakerr2

  April 1, 2020

• Integrating Formal Technology Assessment into an Integrated Healthcare Delivery System: Smart Innovation.

  Landaas EJ, Baird GS, Hansen RN, Flum DR, Sullivan SD. Integrating Formal Technology Assessment into an Integrated Healthcare Delivery System: Smart Innovation. Int J Technol Assess Health Care. 2020;36(1):58-63. doi: 10.1017/S0266462319003465.

  rakerr2

  January 1, 2020

• Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing.

  Landaas EJ, Eckel AM, Wright JL, Baird GS, Hansen RN, Sullivan SD. Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing. Acad Pathol. 2020 Nov 6;7:2374289520968225. d

  rakerr2

  January 1, 2020

• Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources.

  Ramsey SD, Shankaran V, Sullivan SD. Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources. J Clin Oncol. 2019 Jun 24:JCO1802320. doi: 10.1200/JCO.18.02320. [E

  rakerr2

  December 20, 2019

• Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA.

  Steuten L, Garmo V, Phatak H, Sullivan SD, Nghiem P, Ramsey SD. Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA. Appl Health Econ Health Policy. 2019 Oct;17(5):733-740. doi: 10.1007/s40258-019-

  rakerr2

  October 1, 2019

• Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.

  Sullivan SD, Nicholls CJ, Gupta RA, Menon AA, Wu J, Westerbacka J, Bosnyak Z, Frias JP, Bailey TS. Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVE

  rakerr2

  September 1, 2019

• Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.

  Barger S, Sullivan SD, Bell-Brown A, Bott B, Ciccarella AM, Golenski J, Gorman M, Johnson J, Kreizenbeck K, Kurttila F, Mason G, Myers J, Seigel C, Wade JL 3rd, Walia G, Watabayashi K, Lyman GH, Ramsey SD. Effective stakeholder engagement: design and impl

  rakerr2

  June 11, 2019

• Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy.

  Drummond MF, Neumann PJ, Sullivan SD, Fricke FU, Tunis S, Dabbous O, Toumi M. Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy. Value Health. 2019 Jun;22(6):661-668. doi: 10.1016/j.jval.2019.03.012. Epub 201

  rakerr2

  June 1, 2019